Search

Your search keyword '"Piemonti L"' showing total 295 results

Search Constraints

Start Over You searched for: Author "Piemonti L" Remove constraint Author: "Piemonti L" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
295 results on '"Piemonti L"'

Search Results

1. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

3. Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation.

4. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

5. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

7. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age

9. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes

10. Targeting CXCR1/2 does not improve insulin secretion after pancreatic islet transplantation: A phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes

14. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19

15. OP04.09: Impact of assisted reproductive techniques on congenital heart disease: insights from a tertiary care centre and literature review.

16. EP05.08: Antenatal visualisation of the caudo‐thalamic groove at expert fetal neurosonography.

17. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

18. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

19. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

22. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

23. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

24. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

25. The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans

27. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]

29. The impact of proinflammatory cytokines on the beta-cell regulatory landscape provides insights into the genetics of type 1 diabetes

30. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice

31. The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides new insights into the genetics of type 1 diabetes

33. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

34. Human Pancreatic beta Cell lncRNAs Control Cell-Specific Regulatory Networks

35. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes

36. The role of neutrophil‐to‐lymphocyte ratio in men with erectile dysfunction—preliminary findings of a real‐life cross‐sectional study

37. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]

40. Long-term safety of islet autotransplantation in patients with malignancy

42. Dysglycemia after COVID-19 pneumonia: a six-month cohort study

43. COVID-19 and islet transplantation: Different twins

44. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)

45. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

46. COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity

47. Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients

48. Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation

49. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

50. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?

Catalog

Books, media, physical & digital resources